Vorsite Corporation Joins Microsoft’s Digital Pharma Partner Program

Vorsite Corporation, a leading provider of products and services for integrating Microsoft SharePoint with Enterprise Content Management System, today announced that it has accepted an invitation to become a partner in Microsoft’s Digital Pharma initiative. Vorsite solutions help pharmaceutical and life science companies speed clinical trials and other R&D processes by ensuring that researchers can access information quickly and easily while preserving security and data integrity.

According to a recent PhRMA annual survey, pharmaceutical companies spend 71% of their R&D budget on new drug development, with 45% of total R&D going to clinical trials. Vorsite helps companies build clinical trial management systems and other R&D solutions that take advantage of the robust workflow, auditing, and record maintenance capabilities of their ECM system while giving users the ease of use and familiarity of a SharePoint front end. This combination helps pharmaceutical companies maximize speed and efficiency while ensuring regulatory compliance.

"Working with industry-leading companies like Vorsite, Microsoft is enabling pharmaceutical companies to collaborate seamlessly, facilitating timely and accurate decisions," said Steve Shihadeh, general manager, Microsoft Healthcare and Life Sciences. "With the launch of Digital Pharma, Microsoft and its partners are using proven technology to drive out the complexity that's inherent to an industry that is data-intensive and geographically diverse, so that critical drugs can be brought to market as quickly as possible."

Vorsite’s premier product offering is the Enterprise Integration Toolkit, a suite of products built on the .Net Framework that enables integration of Microsoft SharePoint Technologies with Enterprise Content Management systems. Vorsite also offers the ECM QuickStart consulting service, a rapid deployment program that helps customers implement SharePoint as a front-end to an existing ECM system in as little as two weeks.

“Our pharmaceutical customers rely on their Enterprise Content Management systems to ensure regulatory compliance throughout the course of their research and development,” said Vorsite CEO Aaron Nettles. “We help them use SharePoint to bridge the gap between users and those backend systems. The Digital Pharma solutions framework matches our vision of using Microsoft technologies to help pharmaceutical companies streamline the R&D process.”

The Vorsite Enterprise Integration Toolkit and ECM QuickStart are available today. The company will be showcasing additional product and service offerings for the pharmaceutical industry at the Drug Information Association’s annual meeting June 26-30 in Washington, DC. For more information, go to www.vorsite.com.

About Microsoft’s Digital Pharma:
Microsoft’s Digital Pharma provides a practical vision and framework that enables pharmaceutical companies to drive innovation across the enterprise and address strategic value-chain capability requirements. Using proven Microsoft technology, Digital Pharma illustrates how drug manufacturers can achieve speed-to-insight and value-for-cost: two distinct industry imperatives that lead the way for business transformation. More information can be found at http://www.microsoft.com/lifesciences.

About Vorsite
Vorsite is the premier provider of products and services for connecting Microsoft SharePoint to Enterprise Content Management systems. The company helps customers ensure that users can access information supporting key business processes quickly and easily while preserving security and data integrity. Vorsite offers solutions to a wide array of Fortune 1000 companies in energy, pharmaceuticals, and any industry that relies on robust ECM capabilities. The company can be reached at info@vorsite.com or at 1 800 218 7260.

Press Inquires
Aaron Nettles
Vorsite Corporation
5470 Shilshole Ave. NW, Suite 500
Seattle, WA 98107
Fax: +1 206 783 2220
Email: info@vorsite.com

Other product and company names herein may be the property of their respective owners.